Dermatoosteolysis, Kirghizian type

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Dermatoosteolysis, Kirghizian type
Synonyms	Kirghizian type dermatoosteolysis
Pronounce	N/A
Specialty	Medical genetics
Symptoms	Osteolysis, skin laxity, joint hypermobility
Complications	N/A
Onset	Childhood
Duration	Lifelong
Types	N/A
Causes	Genetic mutation
Risks	Family history of the condition
Diagnosis	Genetic testing, clinical evaluation
Differential diagnosis	Ehlers-Danlos syndrome, Marfan syndrome
Prevention	N/A
Treatment	Supportive care, physical therapy
Medication	N/A
Prognosis	Variable, depends on severity
Frequency	Rare
Deaths	N/A

Dermatoosteolysis, Kirghizian Type is a rare genetic disorder characterized by a combination of skin and bone abnormalities. This condition is part of a group of disorders known as dermatoosteolysis syndromes, which involve the degradation of dermis (skin) and osteolysis (bone loss). The Kirghizian type is distinguished by its unique clinical features and genetic background, primarily affecting individuals of Kirghizian descent.

Symptoms and Characteristics

The hallmark symptoms of Dermatoosteolysis, Kirghizian Type, include:

• Skin Abnormalities: Patients may exhibit fragile skin, easy bruising, and a tendency for scars to form with minimal trauma. There may also be an abnormal skin texture, resembling aged skin.
• Bone Abnormalities: Osteolysis, particularly in the hands and feet, leading to deformities and potential loss of function. This can result in short stature, facial anomalies, and dental issues due to jawbone involvement.
• Connective Tissue Involvement: Beyond the skin and bones, other connective tissues may be affected, leading to joint laxity and an increased risk of dislocations.

Causes

Dermatoosteolysis, Kirghizian Type, is believed to be caused by genetic mutations that affect the body's ability to produce or maintain healthy connective tissue. The exact gene(s) involved have not been fully identified, making it a focus of ongoing research. It is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

Diagnosis

Diagnosis of Dermatoosteolysis, Kirghizian Type involves a combination of clinical evaluation and genetic testing. A detailed family history and physical examination are crucial for identifying characteristic symptoms. Genetic testing can confirm the diagnosis by identifying mutations associated with the condition, although the specific genes involved may not always be known.

Treatment

There is no cure for Dermatoosteolysis, Kirghizian Type, and treatment focuses on managing symptoms and improving quality of life. This may include:

• Dermatological Care: To manage skin symptoms, protect against injury, and treat wounds.
• Orthopedic Support: Surgical and non-surgical interventions may be necessary to address bone deformities and improve mobility.
• Physical Therapy: To maintain joint function and prevent contractures.

Prognosis

The prognosis for individuals with Dermatoosteolysis, Kirghizian Type varies depending on the severity of symptoms and the effectiveness of management strategies. Early intervention and supportive care can improve outcomes and quality of life.

See Also

• Genetic disorder
• Osteolysis
• Dermis

   This article is a medical stub. You can help WikiMD by expanding it!